EXAS logo

EXAS
Exact Sciences Corp.

11,330
Mkt Cap
$19.31B
Volume
3.5M
52W High
$101.95
52W Low
$38.81
PE Ratio
-19.14
EXAS Fundamentals
Price
$101.76
Prev Close
$101.74
Open
$101.60
50D MA
$77.92
Beta
0.87
Avg. Volume
9.8M
EPS (Annual)
-$5.59
P/B
7.71
Rev/Employee
$394,123.86
Loading...
Loading...
News
all
press releases
Holocene Advisors LP Acquires 1,404,086 Shares of Exact Sciences Corporation $EXAS
Holocene Advisors LP raised its holdings in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 189.5% during the second quarter, according to its most recent disclosure with the Securities and...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
EXAS Quantitative Stock Analysis
Below is Validea's guru fundamental report for EXACT SCIENCES CORP (EXAS). Of the 22 guru strategies we follow, EXAS rates highest using our P/B Growth Investor model based on the published strategy...
Nasdaq News: Markets·4d ago
News Placeholder
Exact Sciences Corporation $EXAS Shares Sold by Bellevue Group AG
Bellevue Group AG cut its holdings in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 50.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·4d ago
News Placeholder
Exact Sciences Corporation $EXAS Shares Sold by Armistice Capital LLC
Armistice Capital LLC lessened its stake in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 58.1% in the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat·5d ago
News Placeholder
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect MRD Test in Early Triple-Negative Breast Cancer at SABCS
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect molecular residual disease (MRD...
Business Wire·5d ago
News Placeholder
Quantbot Technologies LP Invests $604,000 in Exact Sciences Corporation $EXAS
Quantbot Technologies LP purchased a new stake in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·6d ago
News Placeholder
Exact Sciences (NASDAQ:EXAS) Sets New 52-Week High - Time to Buy?
Exact Sciences (NASDAQ:EXAS) Sets New 12-Month High - Time to Buy...
MarketBeat·6d ago
News Placeholder
Axa S.A. Buys 17,493 Shares of Exact Sciences Corporation $EXAS
Axa S.A. increased its stake in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 3.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned...
MarketBeat·7d ago
News Placeholder
Exact Sciences Corporation $EXAS Shares Acquired by Marshall Wace LLP
Marshall Wace LLP lifted its position in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 1,553.1% in the 2nd quarter, according to the company in its most recent 13F filing with...
MarketBeat·8d ago
News Placeholder
Baird Financial Group Inc. Sells 30,218 Shares of Exact Sciences Corporation $EXAS
Baird Financial Group Inc. reduced its holdings in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 9.7% during the second quarter, according to its most recent Form 13F filing...
MarketBeat·9d ago
<
1
2
...
>

Latest EXAS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.